Alnylam Pharma's total assets for Q4 2024 were $4.24B, an increase of 0.83% from the previous quarter. ALNY total liabilities were $4.17B for the fiscal quarter, a <0.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.